Predicting oral absorption and bioavailability.
暂无分享,去创建一个
[1] M. Boisset,et al. Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] Michael Wiese,et al. Drug-membrane interactions : analysis, drug distribution, modeling , 2002 .
[3] Y Zhang,et al. The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.
[4] M. Abraham,et al. On the partition of ampholytes: application to blood-brain distribution. , 1997, Journal of pharmaceutical sciences.
[5] Malcolm Rowland,et al. Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption , 1996, Pharmaceutical Research.
[6] A. Eckert,et al. Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter. , 2001, Journal of pharmaceutical sciences.
[7] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[8] Bernard Testa,et al. Intermolecular Forces Expressed in 1,2-Dichloroethane/Water Partition Coefficients: A Solvatochromic Analysis , 1997 .
[9] A. Avdeef,et al. pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. , 1993, Journal of pharmaceutical sciences.
[10] D. Massart,et al. Quantitative structure-retention and retention-activity relationships of beta-blocking agents by micellar liquid chromatography. , 2001, Journal of chromatography. A.
[11] U Norinder,et al. Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] C. Bevan,et al. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.
[13] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[14] K. Iseki,et al. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. , 1998, Journal of pharmaceutical sciences.
[15] I. Schoots,et al. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.
[16] K. Luthman,et al. Virtual screening of intestinal drug permeability. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[17] Gianpaolo Bravi,et al. Application of MS-WHIM Descriptors: 3. Prediction of Molecular Properties , 2000 .
[18] I Moriguchi,et al. Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: oral bioavailability. , 1994, Biological & pharmaceutical bulletin.
[19] P. Arnaud,et al. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. , 2001, Journal of pharmaceutical sciences.
[20] Arun K Mandagere,et al. Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.
[21] L. Benet,et al. Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original artic , 1996 .
[22] M. Fromm,et al. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin , 1996, Hepatology.
[23] K. Luthman,et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.
[24] J. D. Elliott,et al. Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity , 1999, Pharmaceutical Research.
[25] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[26] Ruifeng Liu,et al. Development of Quantitative Structure-Property Relationship Models for Early ADME Evaluation in Drug Discovery. 1. Aqueous Solubility , 2001, J. Chem. Inf. Comput. Sci..
[27] C. Kibbey,et al. An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment. , 2001, Journal of pharmaceutical sciences.
[28] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[29] R. Walgren,et al. The Influence of Plasma Binding on Absorption/Exsorption in the Caco‐2 Model of Human Intestinal Absorption , 1999, The Journal of pharmacy and pharmacology.
[30] R. Obach,et al. The prediction of human clearance from hepatic microsomal metabolism data. , 2001, Current opinion in drug discovery & development.
[31] M. Abraham,et al. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. , 1999, Journal of pharmaceutical sciences.
[32] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[33] H. Melhus,et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. , 2001, The Journal of pharmacology and experimental therapeutics.
[34] Han van de Waterbeemd,et al. High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .
[35] R. Conradi,et al. The Influence of Peptide Structure on Transport Across Caco-2 Cells , 1991, Pharmaceutical Research.
[36] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[37] Han van de Waterbeemd,et al. Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .
[38] Denis M. Bayada,et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.
[39] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[40] W. H. Barr,et al. Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. , 1970, Journal of pharmaceutical sciences.
[41] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[42] H vandeWaterbeemd,et al. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998 .
[43] O. H. Chan,et al. Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors. , 1995, Journal of medicinal chemistry.
[44] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[45] H. Lennernäs,et al. Regional Rectal Perfusion: A New in Vivo Approach to Study Rectal Drug Absorption in Man , 2004, Pharmaceutical Research.
[46] A. Seelig,et al. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.
[47] Markus Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features , 2000, J. Chem. Inf. Comput. Sci..
[48] Martyn G. Ford,et al. Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure , 2001, J. Comput. Aided Mol. Des..
[49] A. Avdeef,et al. pH-metric solubility. 3. Dissolution titration template method for solubility determination. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[50] S. Ekins,et al. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance. , 2000, The Journal of pharmacology and experimental therapeutics.
[51] R. Fontana,et al. Molecular and physical mechanisms of first-pass extraction. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[52] S. Anzali,et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.
[53] Gilles Klopman,et al. META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..
[54] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[55] H. Girault,et al. Structure-Lipophilicity Relationships of Neutral and Protonated β-Blockers, Part I, Intra- and Intermolecular Effects in Isotropic Solvent Systems , 1999 .
[56] G Benoni,et al. Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model. , 2001, Journal of pharmaceutical sciences.
[57] P Langguth,et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.
[58] Lawrence X. Yu,et al. Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.
[59] H Matter,et al. Computational approaches towards the rational design of drug-like compound libraries. , 2001, Combinatorial chemistry & high throughput screening.
[60] U Norinder,et al. Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[61] Improved Prediction of In Vivo Peroral Absorption from In Vitro Intestinal Permeability Using an Internal Standard to Control for Intra- and Inter-Rat Variability , 1997, Pharmaceutical Research.
[62] C. Pidgeon,et al. Immobilized Artificial Membranes — screens for drug membrane interactions , 1997 .
[63] D. Shen,et al. Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism , 1996, Clinical pharmacology and therapeutics.
[64] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[65] H. Chow. A physiologically based pharmacokinetic model of zidovudine (AZT) in the mouse: model development and scale-up to humans. , 1997, Journal of pharmaceutical sciences.
[66] P N Judson,et al. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.
[67] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[68] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[69] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[70] K. Iseki,et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.
[71] A. Seelig,et al. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.
[72] Chao-pin Lee,et al. Chemical Approaches to Improve the Oral Bioavailability of Peptidergic Molecules , 1996, The Journal of pharmacy and pharmacology.
[73] T Lavé,et al. Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. , 1999, Journal of medicinal chemistry.
[74] Gerd Folkers,et al. Pharmacokinetic optimization in drug research , 2001 .
[75] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[76] Kevin C. Johnson,et al. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.
[77] U. Norinder,et al. The applicability of computational chemistry in the evaluation and prediction of drug transport properties , 2000 .
[78] P. Morgan,et al. Role of transport proteins in drug absorption, distribution and excretion , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[79] B. Sarkadi,et al. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. , 1994, Biochimica et biophysica acta.
[80] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[81] G Folkers,et al. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[82] O. H. Chan,et al. Physicochemical and drug-delivery considerations for oral drug bioavailability , 1996 .
[83] Ulf Norinder,et al. Theoretical Calculation and Prediction of Caco-2 Cell Permeability Using MolSurf Parametrization and PLS Statistics , 1997, Pharmaceutical Research.
[84] Raimund Mannhold,et al. The hydrophobic fragmental constant approach forcalculating log P in octanol/water and aliphatic hydrocarbon/water systems , 2000 .
[85] J B Houston,et al. Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. , 1997, Drug metabolism reviews.
[86] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[87] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[88] A T Florence,et al. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.
[89] S. Nylander,et al. Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.
[90] I K Pajeva,et al. Structure-activity relationships of multidrug resistance reversers. , 2001, Current medicinal chemistry.
[91] K. Luthman,et al. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.
[92] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[93] R C Chou,et al. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.
[94] L. Dittert,et al. Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. , 1969, Journal of pharmaceutical sciences.
[95] C. Pidgeon,et al. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability. , 1996, Journal of chromatography. A.
[96] P A Carrupt,et al. Evaluation and Prediction of Drug Permeation , 1999, The Journal of pharmacy and pharmacology.
[97] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[98] P. Lundahl,et al. Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions , 1997 .
[99] Claude Roques,et al. Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line , 1998, Pharmaceutical Research.
[100] D. Shen,et al. First‐pass metabolism of midazolam by the human intestine , 1996, Clinical pharmacology and therapeutics.
[101] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[102] S. Jezequel. Fluconazole: Interspecies Scaling and Allometric Relationships of Pharmacokinetic Properties , 1994, The Journal of pharmacy and pharmacology.
[103] Bernard Testa,et al. Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes , 1992 .
[104] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[105] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[106] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .
[107] Y. Sugiyama,et al. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[108] Y Zhang,et al. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.
[109] J. Blake,et al. Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. , 2000, Current opinion in biotechnology.
[110] I. Muegge,et al. "Holistic" in silico methods to estimate the systemic and CNS bioavailabilities of potential chemotherapeutic agents. , 2001, Current topics in medicinal chemistry.
[111] D. Shen,et al. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. , 1997, Advanced drug delivery reviews.
[112] C. Regårdh,et al. Pharmacokinetics of felodipine in patients with liver disease , 2004, European Journal of Clinical Pharmacology.
[113] Caron,et al. Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects. , 1999, Pharmaceutical science & technology today.
[114] J. Beijnen,et al. The pharmacological role of P-glycoprotein in the intestinal epithelium. , 1998, Pharmacological research.
[115] J. Legendre,et al. Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[116] Oleg A. Raevsky,et al. Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs , 1998 .
[117] Per Artursson,et al. Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.
[118] M. Khaledi,et al. Congeneric behavior in estimations of octanol-water partition coefficients by micellar electrokinetic chromatography. , 2000, Analytical chemistry.
[119] M. Zhong,et al. Medium‐throughput pKa screening of pharmaceuticals by pressure‐assisted capillary electrophoresis , 2001, Electrophoresis.
[120] P. Darke,et al. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[121] Hébert. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. , 1997, Advanced drug delivery reviews.
[122] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. J. Eadie,et al. The pharmacokinetics of midazolam in man , 2004, European Journal of Clinical Pharmacology.
[124] Morton B. Brown,et al. Role of intestinal P‐glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine , 1997, Clinical pharmacology and therapeutics.
[125] T Ishizaki,et al. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. , 1997, Pharmacology & therapeutics.
[126] K. Marsh,et al. Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption. , 1996, Journal of medicinal chemistry.
[127] A. Watt,et al. An Increased Throughput Method for the Determination of Partition Coefficients , 2000, Pharmaceutical Research.
[128] M. Strafford,et al. Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[129] Bernard Testa,et al. Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety , 1997 .
[130] Sean Ekins,et al. Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication , 2001, J. Chem. Inf. Comput. Sci..
[131] J. Polli,et al. Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.
[132] Han van de Waterbeemd,et al. Substructure and whole molecule approaches for calculating log P , 2001, J. Comput. Aided Mol. Des..
[133] L. Mayer,et al. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[134] I. Muegge,et al. Computational methods to estimate drug development parameters. , 2001, Current opinion in drug discovery & development.
[135] O. H. Chan,et al. Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans , 1995, Pharmaceutical Research.
[136] K. Terada,et al. Optimized conditions of bio-mimetic artificial membrane permeation assay. , 2001, International journal of pharmaceutics.
[137] Beate I. Escher,et al. Evaluation of Liposome−Water Partitioning of Organic Acids and Bases. 2. Comparison of Experimental Determination Methods , 2000 .
[138] Gary O. Spessard,et al. ACD Labs/LogP dB 3.5 and ChemSketch 3.5 , 1998, J. Chem. Inf. Comput. Sci..
[139] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[140] Hamish Ryder,et al. Prediction of Drug Permeability Based on Grid Calculations , 1999 .
[141] B. Müller,et al. Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.
[142] David J. Begley,et al. Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier , 1998, Pharmaceutical Research.
[143] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[144] E. Kharasch,et al. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[145] Taravat Ghafourian,et al. Hydrogen Bonding Parameters for QSAR: Comparison of Indicator Variables, Hydrogen Bond Counts, Molecular Orbital and Other Parameters , 1999, J. Chem. Inf. Comput. Sci..
[146] R. Tauler,et al. Spectrophotometric determination of pKa values based on a pH gradient flow-injection system , 2000 .
[147] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[148] Han van de Waterbeemd,et al. Lipophilicity in drug action and toxicology , 1996 .
[149] Kristina Luthman,et al. Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties , 1999, Pharmaceutical Research.
[150] M Rowland,et al. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. , 2001, The Journal of pharmacology and experimental therapeutics.
[151] R. Boucher,et al. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. , 1992, The Journal of biological chemistry.
[152] C. Pidgeon,et al. Intestinal Peptide Transport Systems and Oral Drug Availability , 1999, Pharmaceutical Research.
[153] James W. McFarland,et al. Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .
[154] H. van de Waterbeemd,et al. Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.
[155] Pierre Bruneau,et al. Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets , 2001, J. Chem. Inf. Comput. Sci..
[156] M. Machida,et al. High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay , 2001, Journal of biomolecular screening.
[157] H. Waterbeemd,et al. Comparison of passive drug transport through Caco-2 cells and artificial membranes , 1997 .
[158] U Norinder,et al. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[159] G Ecker,et al. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. , 1999, Biochemical pharmacology.
[160] S Agatonovic-Kustrin,et al. Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.
[161] K. Inui,et al. Effects of Intestinal and Hepatic Metabolism on the Bioavailability of Tacrolimus in Rats , 1998, Pharmaceutical Research.
[162] R. Borchardt,et al. A Functional Assay for Quantitation of the Apparent Affinities of Ligands of P-Glycoprotein in Caco-2 Cells , 2001, Pharmaceutical Research.
[163] Ajay,et al. Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.
[164] James W. McFarland,et al. Estimating the Water Solubilities of Crystalline Compounds from Their Chemical Structures Alone , 2001, J. Chem. Inf. Comput. Sci..
[165] S. Yamashita,et al. A new interpretation of salicylic acid transport across the lipid bilayer: implications of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract. , 1998, The Journal of pharmacology and experimental therapeutics.
[166] Ulf Norinder,et al. Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..
[167] S. Goldstein,et al. IAM retention and blood brain barrier penetration , 1998 .
[168] M. Bermejo,et al. Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-fluoroquinolones. , 2000, Journal of pharmaceutical sciences.
[169] B. Müller,et al. Determination of liposome partitioning of ionizable drugs by titration. , 1999, Journal of pharmaceutical sciences.
[170] D. Bucher,et al. Oral Immunization of Rats with Proteinoid Microspheres Encapsulating Influenza Virus Antigens , 1993, Pharmaceutical Research.
[171] O. H. Chan,et al. Use of immobilized artificial membrane chromatography for drug transport applications. , 1998, Journal of pharmaceutical sciences.
[172] H Lennernäs,et al. SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. , 2000, Journal of medicinal chemistry.
[173] H H USSING,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.
[174] A. Avdeef,et al. pH-Metric logP 10. Determination of Liposomal Membrane-Water Partition Coefficients of lonizable Drugs , 1998, Pharmaceutical Research.
[175] I Mahmood,et al. Allometric issues in drug development. , 1999, Journal of pharmaceutical sciences.
[176] Human P‐Glycoprotein Pseudoreceptor Modeling: 3D‐QSAR Study on Thioxanthene Type Multidrug Resistance Modulators , 2001 .
[177] Y. Sugiyama,et al. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[178] W. J. Irwin,et al. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors. , 2000, International journal of pharmaceutics.
[179] J R Chretien,et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. , 1998, Journal of drug targeting.
[180] D A Smith,et al. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.
[181] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[182] G Folkers,et al. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.
[183] Akira Tsuji,et al. Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.
[184] J. Huuskonen,et al. Estimation of aqueous solubility in drug design. , 2001, Combinatorial chemistry & high throughput screening.
[185] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[186] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[187] M. Bermejo,et al. Validation of a biophysical drug absorption model by the PATQSAR system. , 1999, Journal of pharmaceutical sciences.
[188] Shiew-Mei Huang,et al. Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption , 1996, Pharmaceutical Research.
[189] Inman Harvey,et al. Evolutionary computational methods to predict oral bioavailability QSPRs. , 2002, Current opinion in drug discovery & development.
[190] H. Yuasa,et al. Comparative Assessment of D‐Xylose Absorption between Small Intestine and Large Intestine , 1997, The Journal of pharmacy and pharmacology.
[191] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[192] D. Smith,et al. Species differences in metabolism and pharmacokinetics: are we close to an understanding? , 1991, Drug metabolism reviews.
[193] J. Robert,et al. Multidrug resistance reversal agents. , 2003, Journal of medicinal chemistry.
[194] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[195] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.
[196] Albert J. Leo,et al. Calculating log P(oct) with no missing fragments; The problem of estimating new interaction parameters , 2000 .
[197] P Buchwald,et al. Octanol-water partition: searching for predictive models. , 1998, Current medicinal chemistry.
[198] R E White,et al. Pharmacokinetic theory of cassette dosing in drug discovery screening. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[199] G. Amidon,et al. Drug transport and targeting. Intestinal transport. , 1999, Pharmaceutical biotechnology.
[200] P. Stocker,et al. Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[201] M. A. Moseley,et al. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[202] U. Christians,et al. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. , 1998, The Journal of pharmacology and experimental therapeutics.
[203] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[204] L. Escuder-Gilabert,et al. Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[205] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[206] C. Beglinger,et al. Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.
[207] M K Bayliss,et al. High-throughput pharmacokinetics: cassette dosing. , 1999, Current opinion in drug discovery & development.